Selected article for: "functional analysis and gene strategy"
Author: Li, W.; Cha, L.
Title: Genetic studies of diseases: Predicting siRNA efficiency
  • Cord-id: eds4ury8
  • Document date: 2007_4_6
    • ID: eds4ury8
    Snippet: Since the identification of RNA-mediated interference (RNAi) in 1998, RNAi has become an effective tool to inhibit gene expression. The inhibition mechanism is triggered by introducing a short interference double-stranded RNA (siRNA,19~27 bp) into the cytoplasm, where the guide strand of siRNA (usually antisense strand) binds to its target messenger RNA and the expression of the target gene is blocked. RNAi has been widely applied in gene functional analysis, and as a potential therapeutic strat
    Document: Since the identification of RNA-mediated interference (RNAi) in 1998, RNAi has become an effective tool to inhibit gene expression. The inhibition mechanism is triggered by introducing a short interference double-stranded RNA (siRNA,19~27 bp) into the cytoplasm, where the guide strand of siRNA (usually antisense strand) binds to its target messenger RNA and the expression of the target gene is blocked. RNAi has been widely applied in gene functional analysis, and as a potential therapeutic strategy in viral diseases, drug target discovery, and cancer therapy. Among the factors which may compromise inhibition efficiency, how to design siRNAs with high efficiency and high specificity to its target gene is critical. Although many algorithms have been developed for this purpose, it is still difficult to design such siRNAs. In this review, we will briefly discuss prediction methods for siRNA efficiency and the problems of present approaches.

    Search related documents:
    Co phrase search for related documents
    • accurate target and long short: 1
    • acute respiratory syndrome and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and long short: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and long target: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome and loop method: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome and low efficiency: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute respiratory syndrome and low efficiency high: 1, 2, 3, 4
    • acute respiratory syndrome and low high efficiency: 1, 2, 3, 4
    • liver disease and long short: 1, 2, 3, 4
    • long short and low efficiency: 1, 2, 3, 4, 5
    • long short and low efficiency high: 1, 2
    • long short and low high efficiency: 1, 2